Virginie Ancrenaz

Publication Activity (10 Years)

Years Active: 2024-2024
Publications (10 Years): 5

Top Topics

Cerebrospinal Fluid

Platelet Rich Plasma

Top Venues

Cancer research communications

This page only lists publications with an associated author ORCID identifier.

Publications

Rémi Vernet, Eugenio Fernandez, Denis Migliorini, Virginie Ancrenaz, Emily Charrier, Marie-Claude Belkouch, Olivier Von Rohr, Muriel Urwyler, Claudio deVito, Jessica Renaux, Jean Villard, Olivier Rubin, Julien Grogg, Nicolas Mach
A First-in-Human Phase I Clinical Study with MVX-ONCO-1, a Personalized Active Immunotherapy, in Patients with Advanced Solid Tumors. Cancer research communications 4 (8) (2024)
Rémi Vernet, Eugenio Fernandez, Denis Migliorini, Virginie Ancrenaz, Emily Charrier, Marie-Claude Belkouch, Olivier Von Rohr, Muriel Urwyler, Claudio deVito, Jessica Renaux, Jean Villard, Olivier Rubin, Julien Grogg, Nicolas Mach
A First-in-Human Phase I Clinical Study with MVX-ONCO-1, a Personalized Active Immunotherapy, in Patients with Advanced Solid Tumors. Cancer research communications 4 (8) (2024)
Rémi Vernet, Eugenio Fernandez, Denis Migliorini, Virginie Ancrenaz, Emily Charrier, Marie-Claude Belkouch, Olivier Von Rohr, Muriel Urwyler, Claudio deVito, Jessica Renaux, Jean Villard, Olivier Rubin, Julien Grogg, Nicolas Mach
A First-in-Human Phase I Clinical Study with MVX-ONCO-1, a Personalized Active Immunotherapy, in Patients with Advanced Solid Tumors. Cancer research communications 4 (8) (2024)
Rémi Vernet, Eugenio Fernandez, Denis Migliorini, Virginie Ancrenaz, Emily Charrier, Marie-Claude Belkouch, Olivier Von Rohr, Muriel Urwyler, Claudio deVito, Jessica Renaux, Jean Villard, Olivier Rubin, Julien Grogg, Nicolas Mach
A First-in-Human Phase I Clinical Study with MVX-ONCO-1, a Personalized Active Immunotherapy, in Patients with Advanced Solid Tumors. Cancer research communications 4 (8) (2024)
Rémi Vernet, Eugenio Fernandez, Denis Migliorini, Virginie Ancrenaz, Emily Charrier, Marie-Claude Belkouch, Olivier Von Rohr, Muriel Urwyler, Claudio deVito, Jessica Renaux, Jean Villard, Olivier Rubin, Julien Grogg, Nicolas Mach
A first-in-human phase I clinical study with MVX-ONCO-1, a personalized active immunotherapy, in patients with advanced solid tumors. Cancer research communications (2024)